Memory CD8+ T cells are sufficient to alleviate impaired host resistance to influenza A virus infection caused by neonatal oxygen supplementation

Clinical and Vaccine Immunology

Volumn 19, Issue 9, 2012, Pages 1432-1441

  Giannandrea, Matthew ^a,b   Yee, Min ^a   O'Reilly, Michael A ^a   Lawrence, B Paige ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HOST RESISTANCE; HYPEROXIA; INFLUENZA A; INFLUENZA VIRUS A; LUNG INFECTION; MEMORY CD8+ T LYMPHOCYTE; MEMORY T LYMPHOCYTE; NEWBORN; NEWBORN MORBIDITY; NEWBORN MORTALITY; NONHUMAN; OXYGEN THERAPY; POSTINFECTION LUNG INFLAMMATION; PRIMARY INFECTION; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE ACTIVATION; VIRAL CLEARANCE; VIRUS STRAIN;

ANIMALS; ANIMALS, NEWBORN; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DISEASE RESISTANCE; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INFANT, NEWBORN; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MICE; MICE, INBRED C57BL; OXYGEN INHALATION THERAPY;

EID: 84865971496     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00265-12     Document Type: Article

References (47)

1. Bantsimba-Malanda C, et al. 2010. A role for dendritic cells in bleomycin-induced pulmonary fibrosis in mice? Am. J. Respir. Crit. Care Med. 182:385-395.
2. Baraldi E, Filippone M. 2007. Chronic lung disease after premature birth. N. Engl. J. Med. 357:1946-1955. (Pubitemid 350074689)
3. Bender BS, Croghan T, Zhang L, Small PA, Jr. 1992. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J. Exp. Med. 175:1143-1145.
4. Benton KA, et al. 2001. Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells. J. Immunol. 166:7437-7445. (Pubitemid 32525621)
5. Bertram EM, et al. 2004. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo. J. Immunol. 172:981-988. (Pubitemid 38113757)
6. Bertram EM, Lau P, Watts TH. 2002. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection. J. Immunol. 168:3777-3785. (Pubitemid 34298377)
7. Bhatt AJ, et al. 2001. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 164:1971-1980. (Pubitemid 33152338)
8. Cerwenka A, Morgan TM, Dutton RW. 1999. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial. J. Immunol. 163:5535-5543.
9. Coalson JJ, Winter V, deLemos RA. 1995. Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 152:640-646.
10. Cutz E, Chiasson D. 2008. Chronic lung disease after premature birth. N. Engl. J. Med. 358:743-745. (Pubitemid 351240762)
11. D'Angio CT, et al. 2011. Immunogenicity of trivalent influenza vaccine in extremely low-birth-weight, premature versus term infants. Pediatr. Infect. Dis. J. 30:570-574.
12. Doyle LW, et al. 2006. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 118:108-113. (Pubitemid 46071153)
13. Ehrenkranz RA, et al. 2005. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 116:1353-1360. (Pubitemid 46056482)
14. Gunville CF, et al. 2010. Scope and impact of early and late preterm infants admitted to the PICU with respiratory illness. J. Pediatr. 157:209-214.
15. Heron M, et al. 2009. Deaths: final data for 2006. Natl. Vital Stat. Rep. 57:1-134.
16. Hikono H, et al. 2006. T-cell memory and recall responses to respiratory virus infections. Immunol. Rev. 211:119-132. (Pubitemid 43882966)
17. Hillaire ML, et al. 2011. Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal A(H3N2) virus is mediated by virus-specific T cells. J. Gen. Virol. 92:2339-2349.
18. Jobe AH, Bancalari E. 2001. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 163:1723-1729. (Pubitemid 32578778)
19. Jobe AH, Kallapur SG. 2010. Long term consequences of oxygen therapy in the neonatal period. Semin. Fetal Neonatal Med. 15:230-235.
20. Kohlmeier JE, Cookenham T, Roberts AD, Miller SC, Woodland DL. 2010. Type I interferons regulate cytolytic activity of memory CD8(+) T cells in the lung airways during respiratory virus challenge. Immunity 33:96-105.
21. Kohlmeier JE, Woodland DL. 2009. Immunity to respiratory viruses. Annu. Rev. Immunol. 27:61-82.
22. Kreijtz JH, et al. 2007. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine 25:612-620. (Pubitemid 44856111)
23. Kreijtz JH, Fouchier RA, Rimmelzwaan GF. 2011. Immune responses to influenza virus infection. Virus Res. 162:19-30.
24. Lanthier PA, et al. 2011. Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses. Vaccine 29:7849-7856.
25. Lawrence BP, Roberts AD, Neumiller JJ, Cundiff JA, Woodland DL. 2006. Aryl hydrocarbon receptor activation impairs the priming but not the recall of influenza virus-specific CD8+ T cells in the lung. J. Immunol. 177:5819-5828. (Pubitemid 44628795)
26. Lee LY, et al. 2008. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J. Clin. Invest. 118:3478-3490.
27. Liang S, Mozdzanowska K, Palladino G, Gerhard W. 1994. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J. Immunol. 152:1653-1661. (Pubitemid 24075695)
28. Manfras BJ, et al. 2004. Oligoclonal CD8+ T-cell expansion in patients with chronic hepatitis C is associated with liver pathology and poor response to interferon-alpha therapy. J. Clin. Immunol. 24:258-271. (Pubitemid 39030673)
29. Neff-LaFord H, Teske S, Bushnell TP, Lawrence BP. 2007. Aryl hydrocarbon receptor activation during influenza virus infection unveils a novel pathway of IFN-gamma production by phagocytic cells. J. Immunol. 179: 247-255. (Pubitemid 46986540)
30. O'Brien KB, et al. 2012. Impaired wound healing predisposes obese mice to severe influenza virus infection. J. Infect. Dis. 205:252-261.
31. O'Reilly MA, Marr SH, Yee M, McGrath-Morrow SA, Lawrence BP. 2008. Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus. Am. J. Respir. Crit. Care Med. 177: 1103-1110. (Pubitemid 351717569)
32. Sabbagh L, et al. 2006. A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival. Proc. Natl. Acad. Sci. U. S. A. 103:18703-18708. (Pubitemid 44913474)
33. Sasaki Y, et al. 2006. Serum immunoglobulin levels do not affect antibody responses to influenza HA vaccine in preterm infants. Vaccine 24:2208-2212. (Pubitemid 43255165)
34. Scheible K, et al. 2011. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. Vaccine 29:2159-2168.
35. Smith VC, et al. 2004. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. J. Pediatr. 144:799-803. (Pubitemid 38858099)
36. Strutt TM, et al. 2010. Memory CD4+ T cells induce innate responses independently of pathogen. Nat. Med. 16:558-564.
37. Thomas PG, Keating R, Hulse-Post DJ, Doherty PC. 2006. Cell-mediated protection in influenza infection. Emerg. Infect. Dis. 12:48-54. (Pubitemid 43143535)
38. Tu W, et al. 2010. Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J. Virol. 84:6527-6535.
39. Walter EC, Ehlenbach WJ, Hotchkin DL, Chien JW, Koepsell TD. 2009. Low birth weight and respiratory disease in adulthood: a population-based case-control study. Am. J. Respir. Crit. Care Med. 180:176-180.
40. Wang J, et al. 2010. CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice. J. Immunol. 185:7654-7662.
41. Warren TK, Mitchell KA, Lawrence BP. 2000. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cellmediated immune responses to influenza A virus without affecting cytolytic activity in the lung. Toxicol. Sci. 56:114-123. (Pubitemid 30441470)
42. Weisman LE. 2003. Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditions. Pediatr. Infect. Dis. J. 22:S33-S37.
43. Welliver TP, et al. 2007. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J. Infect. Dis. 195:1126-1136. (Pubitemid 46543443)
44. Wynn TA. 2008. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214:199-210. (Pubitemid 351160157)
45. Wynn TA. 2011. Integrating mechanisms of pulmonary fibrosis. J. Exp. Med. 208:1339-1350.
46. Yee M, et al. 2009. Neonatal oxygen adversely affects lung function in adult mice without altering surfactant composition or activity. Am. J. Physiol. Lung Cell. Mol. Physiol. 297:L641-L649.
47. Yee M, et al. 2006. Type II epithelial cells are critical target for hyperoxia-mediated impairment of postnatal lung development. Am. J. Physiol. Lung Cell. Mol. Physiol. 291:L1101-L1111. (Pubitemid 44772072)